Squawk on the Street cover image

SOTS 2nd Hour: Nvidia Hits $4T, The Battle of the Kevins, Exclusive: Snap CEO 7/9/25

Squawk on the Street

00:00

Novo Nordisk's Patent Lapse Opens New Market Opportunities

This chapter examines a critical patent oversight by Novo Nordisk that jeopardizes exclusivity for their weight loss drugs, Ozempic and Wagovi, in Canada. The failure to pay a $450 licensing fee in time could lead to major competition from generic versions in a rapidly expanding market.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app